News

NHS England: Pharma transparency scheme ‘does not go far enough’

By 2016-07-06T11:29:00

Generic drugs

Source: Evgeny Rannev

NHS England says pharma firms’ new transparency scheme ”does not go far enough” because it relies on voluntary disclosure by clinicians of payments received

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Subscribe

to HSJ

Sign into your account here